Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Hedge fund Starboard Value's latest activist campaign targeting Pfizer (NYSE:PFE) has boosted the company's shares in recent ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
On today's episode of Market Domination Overtime, hosts Julie Hyman and Josh Lipton delve into the top stories following ...
Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...
Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback